<DOC>
	<DOCNO>NCT02471742</DOCNO>
	<brief_summary>Nipple areolar-complex ( NAC ) spar mastectomy , extend concept skin-sparing mastectomy , allow leave nipple-areola complex intact provide good cosmetic result . Large operable T2-T3 breast cancer ( BC ) , treat neoadjuvant chemotherapy , may theoretically appear suitable surgical option , alternative conventional mastectomy breast conserve surgery case unfavorable size breast , good response neoadjuvant chemotherapy achieve .</brief_summary>
	<brief_title>NAC Sparing Mastectomy After Neo-adjuvant Chemotherapy</brief_title>
	<detailed_description>From January 2009 May 2013 , 422 BC patient progressively accrue NAC-sparing mastectomy , 361 invasive BC patient underwent NAC-sparing mastectomy first treatment ( NAC-group ) , whereas 61 T2-T3 invasive BC patient underwent surgery primary chemotherapy ( NAC-PC group ) . 151 BC patient underwent primary chemotherapy conventional mastectomy ( PC group ) 2004 2009 , evaluate comparative group respect NAC-PC group . Using propensity score matching , local disease-free survival ( LDFS ) NAC-PC patient first compare PC patient . The NAC-PC cohort compare NAC patient term LDFS use two different match criterion , one tumor size neoadjuvant chemotherapy one tumor size neoadjuvant chemotherapy balance covariates .</detailed_description>
	<criteria>T2T3 N0N1 breast cancer ( NACPC PC group ) . T1T3 N01 M0 breast cancer ( NACgroup ) In series NACsparing mastectomy patient , without treatment neoadjuvant chemotherapy , selection patient NACsparing mastectomy make basis follow criterion : tumor nodule without adherence skin , nipple retraction , retroareolar main duct free neoplastic tissue inside frozen section examination . Furthermore , patient consider still eligible NACsparing mastectomy even tumor lie close proximity ( &lt; 1 cm ) NAC physical radiological examination . ( NACPC PC group ) . Exclusion criterion present study breast cancer patient , particularly T4 breast cancer inflammatory ulcerate breast cancer chemotherapy patient synchronous distant metastasis . Patients affect clinical disease ( i.e . cardiovascular disease ) condition optimal therapeutic strategy exclude . For NACsparing mastectomy , exclusion criterion nipple retraction , Paget 's disease , inflammatory change breast bloody discharge nipple . The study exclude woman prior breast augmentation , heavy smoker , obese patient .</criteria>
	<gender>Female</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>77 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>